MOLINA HEALTHCARE, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $45.4B | $40.6B | $34.1B | $32.0B | $27.8B |
| Operating income | $781.0M | $1.7B | $1.6B | $1.2B | $1.0B |
| Interest expense | $192.0M | $118.0M | $109.0M | $110.0M | $120.0M |
| Pretax income | $589.0M | $1.6B | $1.5B | $1.1B | $875.0M |
| Income tax expense | $117.0M | $410.0M | $373.0M | $271.0M | $216.0M |
| Net income | $472.0M | $1.2B | $1.1B | $792.0M | $659.0M |
| Balance Sheet | |||||
| Cash and equivalents | $4.2B | $4.7B | $4.8B | $4.0B | $4.4B |
| Current assets | $12.4B | $12.8B | $12.5B | $10.1B | $10.1B |
| Total assets | $15.6B | $15.6B | $14.9B | $12.3B | $12.2B |
| Current liabilities | $7.4B | $7.9B | $8.2B | $6.9B | $7.0B |
| Total liabilities | $11.5B | $11.1B | $10.7B | $9.3B | $9.6B |
| Total debt | — | $3.0B | $2.2B | $2.2B | $2.2B |
| Stockholders' equity | $4.1B | $4.5B | $4.2B | $3.0B | $2.6B |
| Cash Flow Statement | |||||
| Cash from operations | -$535.0M | $644.0M | $1.7B | $773.0M | $2.1B |
| Depreciation and amortization | $195.0M | $186.0M | $171.0M | $176.0M | $131.0M |
| Stock-based compensation | $47.0M | $116.0M | $115.0M | $103.0M | $72.0M |
| Capital expenditure | $101.0M | $100.0M | $84.0M | $91.0M | $77.0M |
| Free cash flow | -$636.0M | $544.0M | $1.6B | $682.0M | $2.0B |
| Share repurchases | $1.0B | $1.0B | $0 | $400.0M | $128.0M |
| Impairments | — | $0 | $0 | $208.0M | $0 |
Shares outstanding 52.1M · Free float 90.6%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.